10.1016/j.aca.2025.343820 [DOI] [PubMed] [Google Scholar] Ma L., Cai L., Hu M., Wang J., Xie J., Xing Y., et al
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Even if one chooses not to take a GLP-1 to manage weight loss, adherence to a Mediterranean-style diet, adequate hydration, and resistance training combined with aerobic exercise is recommended for weight loss and preservation of muscle mass.
Drink half a bottle per day, ideally at a regular moment or between meals
Conversely, keeping them restricted forces pharmacies to enforce strict quality audits and avoid these active pharmaceutical ingredients (APIs) entirely
